Novo 500 Pill - Search News

News

Novo Nordisk Shares Fall

The Wall Street Journal on MSN · 1d

Novo Nordisk Shares Fall After Data From New Eli Lilly Pill

The stock fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s blockbuster shots.

Bloomberg · 1d

Novo Nordisk Slides on Pressure From Lilly’s Pill Study

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic.

Washington Examiner on MSN · 1d

Novo Nordisk applies for FDA approval in tightening race for weight loss pill

Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to approve an oral version of its anti-obesity medication, moving ahead in the race between drugmakers to offer a weight loss pill.

BioPharma Dive2d

Novo says it’s submitted obesity pill for FDA approval

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

2d

Novo submits obesity pill for FDA approval, BioPharma Dive reports

Novo Nordisk (NVO) asked the Food and Drug Administration to approve a pill version of its popular weight loss drug in obesity earlier this ...

Novo Seeks FDA Nod for Semaglutide Pill as Oral Obesity Space Heats Up

Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.

2d

Should You Buy The Current Dip In Novo Nordisk Stock?

Novo Nordisk (NYSE:NVO) stock has experienced a significant decline, dropping 35% from over $90 in early March to around $58 ...

1d

Why Novo Nordisk Stock Popped Today

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results